NUSSLOCH, Germany, August 9, 2016 /PRNewswire/ --
Adding to its full line of tissue processors, Leica Biosystems introduces the HistoCore PEARL,a fully enclosed, simple-to-use system that enhances user safety
Leica Biosystems today announced the addition of the HistoCore PEARL to their full line of tissue processors. PEARL is a fully enclosed system providing
(Logo: http://photos.prnewswire.com/prnh/20160802/394877LOGO )
(Photo: http://photos.prnewswire.com/prnh/20160802/394876 )
"We are very excited to expand our tissue processor line up with the addition of HistoCore PEARL," stated Matthias Weber, President of Leica Biosystems. "PEARL consistently provides users the quality, safety and operational efficiency required in today's labs. Ultimately, this results in delivering the high quality output needed for accurate diagnosis."
PEARL offers enhanced user safety through a fully enclosed system. This includes triple fume protection, an external exhaust adapter, and an activated carbon filter - providing added protection for lab staff from sustained reagent exposure, and operational confidence for the user.
The ultra-compact design provides a robust 200 cassette capacity, 3.5L reagent bottles, and three paraffin baths to help maximize run efficiency and maintain an effective workflow. With a small footprint of 600 x 710 x 1320 mm (23.62" x 27.95" x 51.96"), PEARL maximizes laboratory space and allows for added work space productivity.
The simple operation includes easy-to-remember operating procedures on a xylene-resistant, multi-lingual touch-screen interface. This ease of use helps provide reliable output day-to-day, and decreases the potential of operator error.
In addition, PEARL features three pre-validated protocols and a Reagent Management System (RMS) for added flexibility. A convenient USB connection allows the user to download log files and help maintain accurate records.
About Leica Biosystems
Leica Biosystems is a global leader in workflow solutions and automation. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps. Our mission of "Advancing Cancer Diagnostics, Improving Lives" is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. The company is represented in over 100 countries. It has manufacturing facilities in 9 countries, sales and service organizations in 19 countries, and an international network of dealers. The company is headquartered in Nussloch, Germany. Visit LeicaBiosystems.com for more information.
Media Contact(s): Kristin O'Neill, Global Brand Marketing Manager Phone: +1-847-821-3537 LBS-GlobalMarketing@leicabiosystems.com
SOURCE Leica Biosystems
Subscribe to our Free Newsletters!
Acute coronary syndrome (ACS) is a sudden, acute life-threatening condition caused by a dramatic ...
Sclerotherapy is a procedure used to treat spider veins, varicose veins and hemorrhoids by directly ...
HELLP syndrome is a rare but serious complication that affects pregnant women. If detected on time, ...View All